1,2,3-프로판트리올, 중합체, (클로로메틸)옥시란 함유

그림문자(GHS)

• 그림문자(GHS)

  

• 신호 어

  Danger

• 유해·위험 문구

  H315：피부에 자극을 일으킴

  H319：눈에 심한 자극을 일으킴

  H334：흡입 시 알레르기성 반응, 천식 또는 호흡 곤란 등을 일으킬 수 있음

  H335：호흡 자극성을 일으킬 수 있음

• 예방조치문구

  P261：분진·흄·가스·미스트·증기·...·스프레이의 흡입을 피하시오.

  P264：취급 후에는 손을 철저히 씻으시오.

  P264：취급 후에는 손을 철저히 씻으시오.

  P280：보호장갑/보호의/보안경/안면보호구를 착용하시오.

  P285：환기가 잘 되지 않는 곳에서는 호흡기 보호구를 착용하시오

  P302+P352：피부에 묻으면 다량의 물로 씻으시오.

  P304+P341：들이마신 경우,호흡이 어려운 경우 환자를 신선한 공기가 있는 곳으로 옮기고 호흡하기 편한 자세로 안정을 취하게 함

  P305+P351+P338：눈에 묻으면 몇 분간 물로 조심해서 씻으시오. 가능하면 콘택트렌즈를 제거하시오. 계속 씻으시오.

  P321：(…) 처치를 하시오.

  P332+P313：피부 자극이 생기면 의학적인 조치· 조언을 구하시오.

  P342+P311：호흡기 증상이 나타나면 의료기관(의사)의 진찰을 받으시오.

  P362：오염된 의복을 벗고 세척 후에 재사용하기

  P501：...에 내용물 / 용기를 폐기 하시오.

1,2,3-프로판트리올, 중합체, (클로로메틸)옥시란 함유 화학적 특성, 용도, 생산

• 화학적 성질

  The polyglycidyl ether of substituted glycerin is the reaction product of epichlorohydrin and glycerin. Although the exact molecular arrangement in not known, it is of uniform composition.

• 용도

  The polyglycidyl ether of substituted glycerine is obtained as a reaction mixture of epichlorohydrin and glycerin. It is used in conjunction with the epoxy resins in the manufacture of adhesives. Because the compound is generally used in conjunction with a curing agent, frequently active amines, the hazardous properties of these substances must also be considered.

• Carcinogenicity

  Carcinomas were produced on the skin of mice painted with the material from once to thrice weekly over a period of a year. No tumors were produced on rabbit ears in a similar test. Sarcomas were produced in rats by subcutaneous injection. When fed to strain A mice at a concentration of 0.2% in the diet, there was no increase in the incidence of spontaneous pulmonary adenomas compared to controls. In a 6 month tumor promotion study in mice, the material was assessed for both tumor promotion and tumor initiation compared to positive controls of dimethylbenzanthracene (DMBA) and tetradecanoyl phorbol acetate (TPA), respectively. Test materials were applied in 0.1mL quantities twice weekly for 26 weeks, with initiation applications beginning on test day 2 and promotion applications beginning on test day 6. Results for initiation were inconclusive, since a small number of skin masses were observed; however, the authors potentially attributed these to high doses of TPA resulting in repeated injury and healing cycles. As no lesions were observed with the material in combination with DMBA, it was judged to have no potential for tumor promotion.

1,2,3-프로판트리올, 중합체, (클로로메틸)옥시란 함유 준비 용품 및 원자재

1,2,3-프로판트리올, 중합체, (클로로메틸)옥시란 함유 공급 업체

Global(32)Suppliers

1,2,3-프로판트리올, 중합체, (클로로메틸)옥시란 함유 관련 검색